Join our daily newsletter At The Bell to receive exclusive market insights
- Respiri (RSH) begins selling its wheezo device across more than 570 pharmacies within the Sigma Healthcare network across Australia
- Sigma is a respected wholesaler and the owner of pharmacy brands such as Amcal, Guardian, Discount Drug Store and Chemist King
- The wheezo device is used to monitor and manage the symptoms of asthma and it helps sufferers gain a better understanding of their condition
- Respiri is now in discussions with a number of other pharmacies and will make further announcements once discussions are finalised and orders begin
- Shares in Respiri are up 7.14 per cent and are trading at 7.5 cents at 11:50 am AEST
Respiri (RSH) has begun selling its wheezo device across more than 570 pharmacies within the Sigma Healthcare network across Australia.
Sigma is a respected wholesaler and the owner of pharmacy brands such as Amcal, Guardian, Discount Drug Store and Chemist King.
“Sigma is a well-known and trusted pharmacy business whose brands have a long history in the Australian market, that patients frequent when seeking healthcare management advice,” Respiri CEO and Managing Director Marjan Mikel said.
“We look forward to a long and mutual beneficial partnership with Sigma’s retail brands that will deliver better health outcomes for patients with asthma.”
Respiri’s wheezo device is used to monitor and manage the symptoms of asthma.
It provides asthma management diary features, medication usage and reminders, as well as information about symptoms and triggers to help asthma sufferers gain a better understanding of how their condition affects them.
Data can then be shared with caregivers, physicians and other healthcare professionals.
Respiri is now in discussions with a number of other pharmacies and will make further announcements once discussions are finalised and orders begin.
Shares in Respiri were up 7.14 per cent and were trading at 7.5 cents at 11:50 am AEST.
